Traditional protein production methods often involve weeks of trial-and-error to optimize constructs, expression systems, and purification protocols — especially when working with difficult targets. These challenges grow when proteins turn out to be insoluble, unstable, or inactive, making them difficult to use in downstream research. Advances in automated screening and parallelized protein expression now offer a faster route to accessing functional protein variants.
Download this application note to learn:
- How automated expression and purification screens produce soluble, active protein variants in under 48 hours
- Achieving high yield, purity, and reproducibility for drug-relevant proteins
- Confidently scaling up the expression of drug-relevant targets
